• Mar 18, 2026 bone grafts bone graft substitutes and biologics like BMPs Risk of adverse reactions (e.g., inflammatory responses) Potential for graft resorption or failure Regulatory issues surrounding biologic agents Variability in clinical outcomes depending on patient fact By April Schultz
